TBPH

Theravance Biopharma Stock Analysis

AI Rating

Great
  • Quality9/10
  • Growth↑ 9/10
  • Value↑ 5/10
Theravance Biopharma sales and earnings growth
TBPH Growth
Great
  • Revenue Y/Y↑ 27.12%
  • EPS Y/Y↑ 156.31%
  • FCF Y/Y↑ 2078.54%
Theravance Biopharma gross and profit margin trends
TBPH Profitability
Great
  • Gross margin ↑ 100.00%
  • EPS margin↑ 36.50%
  • ROIC 5Y↑ 55.81%
Theravance Biopharma net debt vs free cash flow
TBPH Risk
Great
  • Debt / Equity↓ 0.2
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 19.7

Theravance Biopharma stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗